This is a non-core endpoint: only basic statistics are computed.
Injection of e.g. viscoelastic gel into the vitreous cavity
DM_EYE_OPER_INJECT_GEL_VITR
No definition available.
Endpoint definition
↥
FinnGen phenotype data
392423 individuals
Apply sex-specific rule None
392423
Check conditions
DIABETES_FG
71098
Check pre-conditions, main-only, mode, registry filters
Operations: NOMESCO codes
^CKD15
1 out of 7 registries used, show all original rules.
216
Check minimum number of events None
216
Include endpoints None
216
Remove individuals based on genotype QC
213
DM_EYE_OPER_INJECT_GEL_VITR
Control definitions
Control exclude
DM_EYE_OPER
Control conditions
not DIABETES_FG
Extra metadata
First used in FinnGen datafreeze
DF2
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Injection of e.g. viscoelastic gel into the vitreous cavity
based on the number of shared cases.
Broader endpoints:
- Operations, diabetic retinopathy
- Diabetic retinopathy
- Diabetic retinopathy (more control exclusions)
- Diabetes, varying definitions
- Diabetes mellitus
Narrower endpoints:
None
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 213 | 84 | 129 |
| Unadjusted prevalence (%) | 0.06 | 0.04 | 0.08 |
| Mean age at first event (years) | 52.30 | 48.50 | 54.78 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: DM_EYE_OPER_INJECT_GEL_VITR – Injection of e.g. viscoelastic gel into the vitreous cavity
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Injection of e.g. viscoelastic gel into the vitreous cavity
↥Endpoint not on priority list, no data to show.